This combination of products works together to support foundational health and daily wellness.
Its ability to enhance blood vessel formation and support growth factor expression provides a strong theoretical basis for hair growth applications
70% of customers report seeing and feeling benefits within 16 weeks, including deeper sleep, calmer mood, improved energy, and overall improved health.*
Promising results have been observed for the GLP-1/GIP agonist LY3298176 in overweight or obese people with T2D, noting a weight loss between 0.9 and 11.3 kg in participants using the dual agent compared with 0.4 kg and 2.7 kg in those using placebo or dulaglutide respectively [52]
The STEP 2 trial [2] , which included participants with type 2 diabetes, showed slightly more modest but still substantial results, with 9.6% average weight loss compared to 3.4% with placebo